Nasdaq

Sight Sciences Launches OMNI® Edge Surgical System to Enhance Glaucoma Treatment

Sight Sciences, Inc. has announced the launch of the OMNI® Edge Surgical System, an advanced technology designed for minimally invasive glaucoma surgery (MIGS). The new system will be showcased at the ...
Healio

VIDEO: Omni procedure reduces IOP across all stages of glaucoma

Please provide your email address to receive an email when new articles are posted on . The Omni procedure helped reduce IOP across all severities of glaucoma. The procedure produced a low secondary ...
AOL

UnitedHealthcare Adds Sight Sciences OMNI System To Covered Glaucoma Surgery Procedures

Sight Sciences Inc. (NASDAQ:SGHT) on Tuesday announced that UnitedHealthcare has updated its Glaucoma Surgical Treatments policy to cover goniotomy, trabeculotomy, canaloplasty (ab interno), and ...
Seeking Alpha

Cigna Expands Coverage of Glaucoma Surgical Procedures to Include Canaloplasty and Goniotomy (Trabeculotomy)

MENLO PARK, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing ...
Nasdaq

Sight Sciences Announces Publication of Clinical Data Demonstrating Standalone Effectiveness of the OMNI® Surgical System in Pseudophakic Glaucoma Patients with Uncontrolled ...

Worldwide, more than one million trabecular microbypass stents have been implanted in combination with cataract surgery. Despite glaucoma medications and prior microbypass stenting, target IOP may no ...
Seeking Alpha

Sight Sciences climbs after update on Medicare coverage for glaucoma procedure

Sight Sciences (NASDAQ:SGHT) climbed as much as ~43% on Tuesday, marking its biggest-ever intraday gain after Wells Fargo shrugged off concerns about future Medicare coverage for the company's ...